Filter
663
Filtered Results: 663
Text search:
Ministry
of
Health
and
Ministry
of
Environment
Ghana
Featured
Recommendations
36
New Publications
173
Language
Document type
No document type
376
Studies & Reports
143
Guidelines
62
Manuals
46
Strategic & Response Plan
18
Training Material
11
Situation Updates
3
Fact sheets
3
Resource Platforms
1
Countries / Regions
Ghana
69
Global
33
Sierra Leone
26
Kenya
21
Liberia
20
Nigeria
20
Uganda
19
Africa
19
Malawi
17
Ethiopia
15
Zambia
13
Tanzania
11
Rwanda
11
Guinea
10
Senegal
9
Nepal
9
South Africa
8
Cameroon
7
Zimbabwe
7
Namibia
5
Botswana
5
Latin America and the Carribbean
5
Congo, Democratic Republic of
4
India
4
Mozambique
4
East and Southern Africa
4
Benin
3
West and Central Africa
3
Burkina Faso
2
Mali
2
Somalia
2
Cambodia
2
Indonesia
2
Bangladesh
2
Sudan
2
Eswatini/ Swaziland
2
Paraguay
2
Venezuela
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Togo
1
Haiti
1
Philippines
1
South Sudan
1
Syria
1
Chad
1
Thailand
1
Gambia
1
China
1
Argentina
1
Peru
1
Brazil
1
Ukraine
1
Colombia
1
Ecuador
1
Bolivia
1
Greece
1
Angola
1
Madagascar
1
Lesotho
1
Sri Lanka
1
Chile
1
Middle East and North Africa
1
Western and Central Europe
1
Asia
1
Eastern Europe
1
Russia
1
Gabon
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
241
Public Health
55
Key Resources
48
Women & Child Health
37
Clinical Guidelines
35
Capacity Building
24
Pharmacy & Technologies
7
Toolboxes
Disability
52
HIV
51
Mental Health
43
Planetary Health
41
AMR
33
Caregiver
32
Ebola
22
COVID-19
21
Rapid Response
20
Global Health Education
19
TB
18
NTDs
17
Pharmacy
16
NCDs
10
Refugee
8
Health Financing Toolbox
5
Conflict
4
Cholera
3
Natural Hazards
3
Polio
2
Social Ethics
2
Zika
1
Specific Hazards
1
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system ... indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and performance of key national pharmaceutical structures and processes. Level II indicators measure key outcomes of these structures and processes in the areas of access, product quality and rational use. These indicators can be used to assess progress over time; to compare situations between countries; and to reassess and prioritize efforts based on the results.
This Fact Book gives the results of the assessment of Level I indicators conducted in 2003 and of Level II indicator surveys conducted between 2002 and 2004
The document summarizes the infrastructure and activities for Ebola virus disease (EVD) preparedness that are already in place in the Gambia and identifies opportunities for improvement to strengthe...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that ...
The Strategic Framework for Emergency Preparedness is a unifying framework which identifies the principles and elements of effective country health...
There is a substantial and ever-increasing unmet need for rehabilitation worldwide, which is particularly profound in low- and middle
-income countries. The availability ... accessible and affordable rehabilitation is necessary for many people with health conditions to remain as independent as possible, to participate in education, to be economically productive, and fulfil meaningful life roles.
This manual provides guidance for policymakers on the issue of prehospital trauma care systems. The main areas covered include the organisation of the prehospital trauma care system, capacity develo...
The plan contains the latest available evidence on the extent of insecticide resistance around the world, and puts forward a strategy for global and...
The KMC implementation strategy targets a broad audience. These include policy-makers and programme managers at national, regional and local levels, government ... nongovernmental organizations working in the area of maternal and newborn care, global and national professional associations, public and private hospital management at all levels of care, and facility- and community-based maternal and infant care providers.
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has ado...
The document is structured into five sections. The first presents the key experiences and challenges that justify a renewal of the EPHFs. The second section updates the groundwork for the exercise <... public health and provides a framework to inform the exercise of the new essential functions. The third section proposes a new integrated approach for implementing the EPHFs. The fourth section presents a new list of 11 EPHFs related to each stage of this integrated approach. Finally, in the last section, considerations are put forth to guide EPHF implementation as a means of strengthening the health sector.
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are respo...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are respo...
This guidance document has been produced by WHO to assist blood services in the development of national plans to respond to any emerging infectious threats to the sufficiency or safety of the blood ...
Safe sanitation is essential for health, from preventing infections to improving and maintaining mental and social
well-being. Lack ... adequate sanitation contributes to diarrhoeal diseases, parasitic infections, and undernutrition, as
well as posing significant risks and causing anxiety, especially for women and girls. Achieving universal access to safe
sanitation, which protects health, privacy, and dignity, is a global development goal and a recognized basic human right.
Using Epidemiology to Support Primary Health Care. Updated version of the WHO handbook published in the early 1990's entitled: Manual of Epidemiolo...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit pr...
The toolkit pr...
Safe drinking-water management must consider drinking-water quality, acceptability and quantity in the context of public health protection. In this...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out ... this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are disappearing, but other serogroups (e.g. NmW, NmX and NmC) still cause epidemics, albeit at a lower frequency and of a smaller size. Due to these changes, WHO organized the review of the evidence to provide recommendations for epidemic control, related to operational thresholds for investigation and response to outbreaks, the use of rapid diagnostic tests, antibiotic regimens in epidemics, and prophylaxis for household contacts of cases
Small drinking-water supplies commonly experience operational, managerial, technical and resourcing challenges that impact their ability to deliver safe and reliable services. The needs ... opportunities associated with these supplies therefore warrant explicit consideration in policies and regulations.
These Guidelines, specifically tailored to small water supplies, build on over 60 years of guidance by the World Health Organization (WHO) on drinking-water quality and safety. They focus on establishing drinking-water quality regulations and standards that are health based and context appropriate; on proactively managing risks through water safety planning and sanitary inspections; and on carrying out independent surveillance. The guidance is intended primarily for decision-makers at national and subnational levels with responsibility for developing regulatory frameworks and support programmes related to these activities. Other stakeholders involved in water service provision will also benefit from the guidance in this document.
Designed to be practical and accessible, these Guidelines offer clear guidance that is rooted in the principle of progressive improvement. State-of-the-art recommendations and implementation guidance are provided, drawn from a comprehensive evidence review and established good practices. Additionally, case examples are provided from countries and areas around the world to demonstrate how the guidance in this publication has been implemented in practice in a wide variety of contexts.
Together with WHO’s 2024 Sanitary inspection packages – a supporting tool for the Guidelines for drinking-water quality: small water supplies, these Guidelines update and supersede WHO’s 1997 Guidelines for drinking-water quality. Volume 3: surveillance and control of community supplies. Key changes to this updated publication include a greater focus on preventive risk management and a broader range of small water supplies covered, including those managed by households, communities and professional entities.
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water ... healthcare services. Up to 150 million adolescent girls and women are estimated to be at risk of FGS and about 16–56 milion womens are living with FGS, with the majority of these in sub-Saharan Africa. The variability of these estimates points to the fact that this neglected tropical disease is not well studied and frequently not prioritized by local, regional, and global health policy makers.
